Nitric oxide: an antioxidant and neuroprotector

Area of Science:

• Neuroscience
• Toxicology
• Biochemistry

Background:

• The role of nitric oxide (NO) in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity is controversial, with conflicting indirect evidence.
• Oxidative stress, particularly hydroxyl radical (OH) generation, is implicated in MPTP neurotoxicity.

Purpose of the Study:

• To review and clarify the evidence regarding the influence of antioxidants, including NO and NO donors, on MPTP-induced dopaminergic neurotoxicity.
• To investigate the direct role of NO in MPTP neurotoxicity and its mechanism of action.

Main Methods:

• Review of existing literature on MPTP neurotoxicity, oxidative stress, and antioxidant effects.
• Analysis of studies involving MPTP administration in mice and assessment of OH generation in the striatum.
• Evaluation of the effects of NO donors on MPTP-induced dopaminergic neurotoxicity and OH scavenging.

Main Results:

• Systemic MPTP administration induces dose-dependent OH generation in the mouse striatum, and OH scavengers protect dopaminergic neurons.
• MPTP does not alter inducible-NOS mRNA levels or expression in the substantia nigra (SN) or striatum.
• NO donors, such as nitroglycerine, attenuate MPTP-induced dopamine depletion by scavenging OH, acting as antioxidants.

Conclusions:

• NO protects against MPTP-induced OH-mediated nigrostriatal lesions by acting as an antioxidant.
• The findings suggest that NO's protective effect in MPTP neurotoxicity is primarily due to its ability to scavenge hydroxyl radicals.